Skip to content

Double low dose study of dynamic scanning with diluted iso-osmolar contrast medium in head and neck dual-source CT angiography

Double low dose study of dynamic scanning with diluted iso-osmolar contrast medium in head and neck dual-source CT angiography

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039938
Enrollment
Unknown
Registered
2020-11-14
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral and carotid artery disease

Interventions

Double low dose group:To use double low-dose CT angiography of head and neck with diluted isotonic contrast medium
Conventional dose group:Routine head and neck CTA, with no low-dose examination

Sponsors

Changzhou Wujin People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18-80 years old; 2. Subjects with BMI < 30 kg / m2; 3. Patients with suspected or confirmed head and neck artery disease; 4. The patients who volunteered to join the study signed the informed consent form and had good compliance.

Exclusion criteria

Exclusion criteria: 1. Subjects allergic to iodized contrast media; 2. Patients with severe hyperthyroidism, renal insufficiency and decompensated cardiac insufficiency; 3. Subjects with obvious moving artifacts; 4. Subjects with failed angiography.

Design outcomes

Primary

MeasureTime frame
CT value of blood vessel;

Secondary

MeasureTime frame
Signal-to-Noise Ratio, SNR;Contrast-to-Noise Ratio, CNR;body Mass Index (BMI);total amount of intake of contrast medium;radiation dose;venous contamination;image quality (subjective evaluation);

Countries

China

Contacts

Public ContactWu Honglin

Changzhou Wujin People's Hospital

wuhljs@163.com+86 519 85579087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026